Standard BioTools, Inc. (LAB)
0.6056
-0.03
(-4.72%)
USD |
NASDAQ |
Oct 23, 16:00
0.6001
-0.01
(-0.91%)
After-Hours: 20:00
Standard BioTools Net Income (Quarterly) : -21.52M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.52M |
| March 31, 2026 | -14.63M |
| December 31, 2025 | 13.90M |
| September 30, 2025 | -31.68M |
| June 30, 2025 | -17.67M |
| March 31, 2025 | -23.37M |
| December 31, 2024 | -27.17M |
| September 30, 2024 | -21.92M |
| June 30, 2024 | -25.44M |
| March 31, 2024 | -32.16M |
| December 31, 2023 | -19.78M |
| September 30, 2023 | -21.00M |
| June 30, 2023 | -17.04M |
| March 31, 2023 | -16.84M |
| December 31, 2022 | -20.84M |
| September 30, 2022 | -29.43M |
| June 30, 2022 | -63.54M |
| March 31, 2022 | -76.29M |
| December 31, 2021 | -9.429M |
| September 30, 2021 | -13.84M |
| June 30, 2021 | -17.14M |
| March 31, 2021 | -18.82M |
| December 31, 2020 | -18.03M |
| September 30, 2020 | -5.999M |
| June 30, 2020 | -13.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.98M |
| December 31, 2019 | -12.68M |
| September 30, 2019 | -12.89M |
| June 30, 2019 | -13.75M |
| March 31, 2019 | -25.46M |
| December 31, 2018 | -14.78M |
| September 30, 2018 | -14.75M |
| June 30, 2018 | -16.24M |
| March 31, 2018 | -13.25M |
| December 31, 2017 | -10.46M |
| September 30, 2017 | -15.94M |
| June 30, 2017 | -16.93M |
| March 31, 2017 | -17.20M |
| December 31, 2016 | -17.70M |
| September 30, 2016 | -19.79M |
| June 30, 2016 | -18.62M |
| March 31, 2016 | -19.88M |
| December 31, 2015 | -12.88M |
| September 30, 2015 | -9.269M |
| June 30, 2015 | -15.24M |
| March 31, 2015 | -15.93M |
| December 31, 2014 | -10.94M |
| September 30, 2014 | -13.79M |
| June 30, 2014 | -12.68M |
| March 31, 2014 | -15.41M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Illumina, Inc. | 207.00M |
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Bruker Corp. | -50.90M |
| Danaher Corp. | 1.207B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 20.10M |
| Total Expenses (Quarterly) | 41.63M |
| EPS Diluted (Quarterly) | -0.0685 |
| Enterprise Value | -211.16M |
| Gross Profit Margin (Quarterly) | 52.40% |
| Profit Margin (Quarterly) | -107.1% |
| Earnings Yield | -37.24% |
| Normalized Earnings Yield | -27.44 |